Search results
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
Benzinga via Yahoo Finance· 5 days agoEli Lilly And Co (NYSE:LLY) has reportedly reached a settlement agreement with a medi spa that sold...
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
Motley Fool via Yahoo Finance· 1 day agoThey're both based on the same molecule, but regulators approved the product for type 2 diabetes...
Everything you need to know about semaglutide weight loss drugs
New Scientist· 6 days agoOzempic and Wegovy are brand names for the drug semaglutide. Many countries have approved Wegovy for...
Lilly settles with spa selling knockoff versions of its popular diabetes, weight-loss drugs -...
Indianapolis Business Journal· 5 days agoEli Lilly and Co. has entered a settlement agreement with a South Carolina medical spa that was...
New ‘Godzilla’ weight loss jab is even better than Ozempic, study suggests
The Telegraph via Yahoo News· 7 days ago“We know that tirzepatide (Mounjaro) is the King Kong of the GLP-1s. And when...results in 2026....
2 Top Pharma Stocks That Just Keep Getting Better and Better
Motley Fool via Yahoo Finance· 6 days agoRather than focus on the quantitative changes in medical metrics that the drug caused, it's far more...
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 5 days agoAlthough as it still has no drugs approved by the Food and Drug Administration, incremental updates...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 4 days agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says
Reuters via Yahoo News· 5 days agoNovo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier...
Navigating GLP-1 insurance coverage with the right pharmacy benefits manager
BenefitsPRO· 5 days agoWith the arrival of Ozempic, Wegovy and other GLP-1 agonists, a weight-loss drug boom is sweeping...